跳至主要内容
临床试验/NCT05037240
NCT05037240已完成不适用

Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of an Oral Nutritional Supplement Based on Quercetin in the Prevention of Covid-19 Infection for a Duration of 3 Months

Azienda di Servizi alla Persona di Pavia2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年1月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Prevention of Covid-19 infection

研究概览

简要总结

Quercetin is a flavonol, a subclass of flavonoid compounds. Of the flavonol molecules, quercetin is the most abundant in fruit and vegetables. Quercetin flavonol is characterized by 3 crucial properties: antioxidant, anti-inflammatory and immunomodulatory. The combination of these 3 properties makes quercetin an excellent candidate for dealing with situations in which oxidative stress, inflammation and the immune system are involved. The purpose of the study is to evaluate the effectiveness of an oral nutritional supplement based on quercetin in the prevention of Covid-19 infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Absence of Covid-19 infection

排除标准

  • Previous Sars-Cov-2 infection demonstrated with antibody positivity through venous sampling
  • Demonstrated presence of Sars-Cov-2 through a nasopharyngeal antigenic swab before the start of oral nutritional supplementation

结局指标

主要结局

Prevention of Covid-19 infection

时间窗: Absence of Covid-19 infection at 3 months

A nasopharyngeal antigenic swab

次要结局

未报告次要终点

研究者

发起方
Azienda di Servizi alla Persona di Pavia
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Quercetin in the Prevention of Covid-19 Infection | 临床试验